GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human 15-ketoprostaglandin delta-13- reductase in complex with NADPH and nicotinamide

Analyse Crystal structure of human 15-ketoprostaglandin delta-13- reductase in complex… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ZB7
Type
protein
Length
350 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Prostaglandin reductase 2
EC
1.3.1.48
UniProt
Q8N8N7
Ligands
NDP, NCA
Pockets
2 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 33% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProstaglandin reductase 2 (EC 1.3.1.48)protein35033% helix, 28% strandQ8N8N7

Ligands and binding sites

  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • NCA · Nicotinamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17570.820.8575NDP, NCA
22670.630.8030empty

Compared structures

  • 2ZB7 · Crystal structure of human 15-ketoprostaglandin delta-13-reductase in complex with NADPH… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8N8N7 · AlphaFold monomer V2.0 prediction for prostaglandin reductase 2 (Q8N8N7) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.